Patient Satisfaction and Postoperative Outcomes Following All-on-Four Implant Surgery Under Analgosedation
1 other identifier
observational
30
1 country
1
Brief Summary
Objective: To evaluate patient satisfaction, postoperative pain, inflammatory re-sponse, and analgesic consumption following All-on-Four implant surgery performed under analgosedation. Methods: This prospective clinical study will include 30 adult patients classified as ASA physical status I-II who were scheduled for elective full-arch rehabilitation using the All-on-Four protocol under analgosedation. Patients with contraindications to sedation, cognitive impairment, or emergency indications will be excluded. Postoperative pain and swelling will be assessed using a visual analogue scale (VAS) up to 72 hours. Real analgesic consumption will be recorded during the first three postoperative days. Systemic inflammatory response will be evaluated by serum C-reactive protein (CRP) levels measured preoperatively and on postoperative day 3. Patient experience with anesthetic management will be assessed using a structured questionnaire.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2026
CompletedFirst Submitted
Initial submission to the registry
February 11, 2026
CompletedFirst Posted
Study publicly available on registry
March 10, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedApril 13, 2026
January 1, 2026
3 months
February 11, 2026
April 7, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Patient Reported postoperative pain andswelling
The primary outcome measures included patient-reported postoperative pain and swelling, analgesic use and systemic inflammatory response. Postoperative pain intensity and swelling were assessed using a 10-point Visual Analogue Scale (VAS), where 0 indicated the absence of symptoms and 10 indicated the maximum perceived severity. Assessments were performed preoperatively and at 2, 6, 12, 24, 48, and 72 hours postoperatively.
"From enrollment to the end of treatment at 3 days"
Rescue analgesic consumption
Rescue analgesic consumption was recorded for each patient during the first three postoperative days and quantified based on the total number of tablets consumed and daily dose. Analgesic intake was used as an indirect indicator of postoperative discomfort.
From surgery up to 3rd postoperative day
The systemic inflammatory response
To evaluate the systemic inflammatory response, serum C-reactive protein (CRP) levels were measured preoperatively and on postoperative day 3 using standard laboratory procedures.
"From enrollment to the end of treatment at 3 days"
Secondary Outcomes (1)
Patient experience with analgosedation
"From enrollment to the end of treatment at 3 days"
Study Arms (1)
Analgosedation
Adult patients classified as ASA physical status I-II who were scheduled for elective full-arch rehabilitation using the All-on-Four protocol under analgosedation
Interventions
The elective full-arch rehabilitation using the All-on-Four protocol under analgosedation
Eligibility Criteria
This prospective clinical study will include 30 patients classified as ASA physical status I-II who need to underwent full-arch rehabilitation using the All-on-Four implant concept
You may qualify if:
- Adult patients scheduled for elective full-arch implant rehabilitation
- ASA physical status I or II
- Ability to understand the study procedures and provide written informed consent
You may not qualify if:
- Emergency dental or surgical intervention
- Pregnancy
- Patients with cognitive impairment or psychiatric conditions affecting reliable outcome reporting
- Patients with contraindications to analgo-sedation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Zagreblead
- St. Catherine Specialty Hospitalcollaborator
Study Sites (1)
Dental Center, St.Caherine Hospital
Zagreb, Croatia
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Sinior assistant at Department of Oral Surgery
Study Record Dates
First Submitted
February 11, 2026
First Posted
March 10, 2026
Study Start
January 1, 2026
Primary Completion
March 31, 2026
Study Completion
April 1, 2026
Last Updated
April 13, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, CSR
- Time Frame
- 1.1.2027 till 31.12.2027
All data if needed.